52058 Federal Register / Vol. 73, No. 174 / Monday, September 8, 2008 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; National Children’s 

Study Repository, RFP: NIH–NICHD–NCS–

09–07. 

Date: October 6, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sathasiva B. Kandasamy, 

PHD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institute of Child Health, and Human 

Development, 6100 Executive Boulevard, 

Room 5B01, Bethesda, MD 20892–9304, (301) 

435–6680, skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: August 28, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–20647 Filed 9–5–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Communication 

Disorders Review Committee. 

Date: October 15–16, 2008. 

Time: October 15, 2008, 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Time: October 16, 2008, 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Shiguang Yang, DVM, 

PhD, Scientific Review Administrator, 

Scientific Review Branch, Division of 

Extramural Activities, NIDCD, NIH, 6120 

Executive Blvd., Suite 400C, Bethesda, MD 

20892, 301–435–1425, 

yangshi@nidcd.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: August 29, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–20681 Filed 9–5–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Live, Attenuated Virus 

Vaccines Against RSV, PIV, and hMPV 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of worldwide 

exclusive license to practice the 

invention embodied in: 

RSV Technologies 

(1) U.S. Patents 5,993,824 (issued 

November 30, 1999) and associated 

pending U.S. patent applications, serial 

numbers 10/934,003 (filed September 2, 

2004) and 10/722,000 (filed November 

25, 2003) and associated foreign rights 

from PCT applications PCT/US97/12269 

(filed July 15, 1997) and PCT/US00/ 

08802 (filed March 31, 2000) (HHS 

references E–142–1996/0,3,4); 

(2) U.S. Patent 6,713,066 (issued 

March 30, 2004) and associated pending 

U.S. patent application, serial number 

11/011,502 (filed December 13, 2004) 

and associated foreign rights from PCT 

application PCT/US00/18534 (HHS 

reference E–194–1999/0); 

(3) PCT application PCT/US00/09695 

and associated foreign rights therefrom 

(HHS reference E–040–1999/0); 

(4) U.S. patent applications, serial 

numbers 11/054,343 (filed February 9, 

2001) and 11/033,055 (filed January 10, 

2005), and associated foreign rights from 

PCT application PCT/US01/20107 (HHS 

reference E–225–2000/0). 

PIV Technologies 

(1) U.S. Patents 6,410,023 (issued June 

25, 2002); 7,208,161 (issued April 24, 

2007); 7,314,631 (issued January 1, 

2008); 7,250,171 (issued July 31, 2007); 

and pending U.S. patent application, 

serial number 11/785,364 (filed April 

17, 2007), and associated foreign rights 

through PCT applications PCT/US98/ 

10551 (filed May 22, 1998) and PCT/ 

US00/18523 (filed July 6, 2000) (filed 

December 8, 2000) (HHS references E–

089–1997/2,3,4,5,6,7); 

(2) U.S. patent application, serial 

number 10/667,141 (filed September 18, 

2003) and associate foreign rights from 

PCT/US03/29685 (filed September 18, 

2003) (HHS reference E–092–2002/0); 

(3) U.S. patent application (serial 

number pending, filed January 10, 2006) 

and associated foreign rights from PCT/ 

US2006/000666 (filed January 10, 2006) 

(HHS reference E–295–2004/0); 

(4) U.S. patent application, serial 

number 10/302,547 (filed November 21, 

2002) and associated foreign rights from 

PCT/US02/37688 (filed November 21, 

2002) (HHS reference E–280–2001/0). 

hMPV Technology 

(1) U.S. patent application, serial 

number 10/789,400 (filed February 27, 

mstockstill on PROD1PC66 with NOTICES